India’s TB screening drive has uncovered a major number of cases, highlighting the scale of hidden tuberculosis. More than 2.2 crore people were screened during the 100-day campaign, with over 7 lakh TB cases detected. Union Health Minister...
Pharma exports, drug regulation, and rare disease therapies are signaling a broader shift across the pharmaceutical sector
Fertility drug regulation has come under scrutiny after the Central Drugs Standard Control Organization flagged the unauthorized manufacture
Ebola outbreak developments in the Democratic Republic of Congo have taken another serious turn, with confirmed cases rising to 4,449 and deaths reaching 2,061
The oral semaglutide race in India has hit a fresh legal hurdle. The Delhi High Court has asked Sun Pharma to seek its approval before launching the tablets.
Hyderabad is set for a major boost as Amgen plans a new R&D center in the city. The center will strengthen the company’s research capabilities in India. It will also expand Hyderabad’s role in global drug research and innovation.
The latest developments across drug regulation, R&D, and healthcare expansion signal important shifts in the global and Indian pharmaceutical industry
The Ebola death toll in the Democratic Republic of Congo has crossed 2,000 as the country battles a rapidly spreading outbreak. The outbreak has already claimed 2,011 confirmed deaths across five provinces.
India’s MedTech industry is entering a new phase of growth as domestic manufacturing, technology innovation, global partnerships, and healthcare demand reshape the medical devices sector.
Biosafety testing is becoming increasingly important as biopharmaceutical companies develop complex biologics and advanced therapies across Asia-Pacific